Literature DB >> 23955635

Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children.

H Sano1, R Kobayashi1, A Iguchi2, D Suzuki1, K Kishimoto1, K Yasuda1, K Kobayashi1.   

Abstract

Idiopathic pneumonia syndrome (IPS) is a critical complication following allogeneic hematopoietic SCT (HSCT); however, few reports have analyzed the risk factors for IPS in children. A total of 210 consecutive pediatric patients, including 131 boys and 79 girls, with various hematologic malignancies, aplastic anemia or solid tumors who underwent allogeneic HSCT were analyzed to clarify the incidence and risk factors for IPS. Patient and transplantation characteristics after allogeneic HSCT were compared between patients with and without IPS. Cumulative incidence rates of IPS 120 days after allogeneic HSCT were 6.7% (14/210). Of 14 patients with IPS, 11 (78.6%) died after developing IPS. The presence of prior HSCT was more frequent in patients with IPS (IPS group) than in those without IPS (non-IPS group; 35.7 vs 12.8%, respectively, P=0.018). The IPS group contained more patients with acute GVHD (grade II-IV) than the non-IPS group (50.0 vs 18.9%, respectively, P=0.006). The association of these two factors with IPS was further confirmed by multivariate analysis. We should be aware of these risk factors in patients who have undergone allogeneic HSCT.

Entities:  

Mesh:

Year:  2013        PMID: 23955635     DOI: 10.1038/bmt.2013.123

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  24 in total

1.  Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.

Authors:  Aldo Della Volpe; Andrés José María Ferreri; Claudio Annaloro; Paola Mangili; Alberto Rosso; Riccardo Calandrino; Eugenio Villa; Giorgio Lambertenghi-Deliliers; Claudio Fiorino
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

2.  High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.

Authors:  R Tizon; N Frey; D F Heitjan; K S Tan; S C Goldstein; E O Hexner; A Loren; S M Luger; R Reshef; D Tsai; D Vogl; J Davis; M Vozniak; B Fuchs; E A Stadtmauer; D L Porter
Journal:  Bone Marrow Transplant       Date:  2012-02-06       Impact factor: 5.483

Review 3.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

4.  A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989.

Authors:  K Atkinson; I Nivison-Smith; A Dodds; A Concannon; S Milliken; K Downs
Journal:  Bone Marrow Transplant       Date:  1998-04       Impact factor: 5.483

5.  The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Authors:  Gregory A Yanik; Vincent T Ho; John E Levine; Eric S White; Thomas Braun; Joseph H Antin; Joel Whitfield; Joseph Custer; Dawn Jones; James L M Ferrara; Kenneth R Cooke
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

Review 6.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

7.  Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.

Authors:  Takahiro Fukuda; Robert C Hackman; Katherine A Guthrie; Brenda M Sandmaier; Michael Boeckh; Michael B Maris; David G Maloney; H Joachim Deeg; Paul J Martin; Rainer F Storb; David K Madtes
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

8.  Interstitial pneumonitis after BMT: 15 years experience in a single institution.

Authors:  A Grañena; E Carreras; C Rozman; C Salgado; J Sierra; M Algara; M Rovira; A Valls
Journal:  Bone Marrow Transplant       Date:  1993-06       Impact factor: 5.483

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.

Authors:  S W Crawford; G Longton; R Storb
Journal:  Bone Marrow Transplant       Date:  1993-09       Impact factor: 5.483

View more
  9 in total

1.  TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).

Authors:  Gregory A Yanik; Stephan A Grupp; Michael A Pulsipher; John E Levine; Kirk R Schultz; Donna A Wall; Bryan Langholz; Christopher C Dvorak; Keith Alangaden; Rakesh K Goyal; Eric S White; Jennifer M Collura; Micah A Skeens; Saada Eid; Elizabeth M Pierce; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

2.  Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.

Authors:  Ryoji Kobayashi; Tetsuo Mitsui; Naoto Fujita; Tomoo Osumi; Tomohiro Aoki; Kazunari Aoki; Ritsuro Suzuki; Takahiro Fukuda; Toshihiro Miyamoto; Koji Kato; Hirohisa Nakamae; Hiroaki Goto; Tetsuya Eto; Masami Inoue; Takehiko Mori; Kiminori Terui; Masahito Onizuka; Katsuyoshi Koh; Yuhki Koga; Tatsuo Ichinohe; Akihisa Sawada; Yoshiko Atsuta; Junji Suzumiya
Journal:  Int J Hematol       Date:  2016-10-27       Impact factor: 2.490

3.  Noninfectious complications of hematopoietic cell transplantation.

Authors:  Kirsten M Williams
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

5.  Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.

Authors:  Robert F Tamburro; Kenneth R Cooke; Stella M Davies; Samuel Goldfarb; James S Hagood; Ashok Srinivasan; Marie E Steiner; Dennis Stokes; Nancy DiFronzo; Nahed El-Kassar; Nonniekaye Shelburne; Aruna Natarajan
Journal:  Ann Am Thorac Soc       Date:  2021-03

6.  Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.

Authors:  Maria Otth; Christina Schindera; Tayfun Güngör; Marc Ansari; Katrin Scheinemann; Fabiën N Belle; Philipp Latzin; Nicolas von der Weid; Claudia E Kuehni
Journal:  Bone Marrow Transplant       Date:  2020-11-25       Impact factor: 5.483

Review 7.  Early Onset Noninfectious Pulmonary Syndromes after Hematopoietic Cell Transplantation.

Authors:  Lisa K Vande Vusse; David K Madtes
Journal:  Clin Chest Med       Date:  2017-06       Impact factor: 2.878

Review 8.  Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation.

Authors:  Vivek N Ahya
Journal:  Clin Chest Med       Date:  2017-09-19       Impact factor: 2.878

9.  Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review.

Authors:  Dan Tomomasa; Takeshi Isoda; Noriko Mitsuiki; Motoi Yamashita; Aoi Morishita; Takahiro Tomoda; Tsubasa Okano; Akifumi Endo; Takahiro Kamiya; Masakatsu Yanagimachi; Kohsuke Imai; Hirokazu Kanegane; Masatoshi Takagi; Tomohiro Morio
Journal:  Clin Case Rep       Date:  2021-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.